MedPath

Pulmonary Endarterectomy Guided by CT Scanning for Patients With Chronic Thromboembolic Pulmonary Hypertension----PEACT

Not Applicable
Conditions
Chronic Thromboembolic Pulmonary Hypertension
Pulmonary Embolism
Interventions
Diagnostic Test: 3-D CT scanning
Registration Number
NCT03795740
Lead Sponsor
Sheng Liu
Brief Summary

This study is a effectiveness study of the application of high-definition enhanced computed-tomography for patients with chronic thromboembolic pulmonary hypertension(CTEPH).The patients with CTEPH was randomized into 2 groups,precise pulmonary endarterectomy group(guided by enhanced CT scanning) and traditional pulmonary endarterectomy group,the hemodynamic changes tested with right sided heart catherization from baseline to post-operative period and end-point including peri-operative deaths,follow-up mortality,follow-up parameters of ultrasonic cardiogram(UCG),right-sided heart catherization(RHC),nuclear magnetic resonance imaging(MRI),cardiac pulmonary exercise test(CPET) are documented,so as to compare the prognosis between these 2 groups.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
72
Inclusion Criteria
  • Definite diagnosed with chronic thromboembolic pulmonary hypertension with the right-sided cathrization and pulmonary angiography;
  • The computed tomography imaging implied that the location of the embolism could be reached with surgeries;
Exclusion Criteria
  • Beyond the age limit described above,or combined with other severe conditions such as severe organ dysfunction and considered contraindicated for surgical therapy by the cardiac surgeons;
  • Without the consent by the patient or his/her families;
  • Acute pulmonary embolism;
  • Pulmonary sarcoma;
  • Pulmonary arteritis;
  • Combined with cardiogenic pulmonary hypertension or idiopathic pulmonary hypertension;

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo3-D CT scanningtraditional PEA therapy solely by surgical probe and traditional CT scanning/pulmonary angiography method
Precise3-D CT scanningprecise PEA therapy with the guide of 3-D imaging techniques
Primary Outcome Measures
NameTimeMethod
Change from Baseline pulmonary mean pressure within 1 monthwithin 1 month before and after pulmonary endarterectomy surgery

Mean pulmonary pressure result tested by right-sided heart

Change from Baseline pulmonary systolic pressure within 1 monthwithin 1 month before and after pulmonary endarterectomy surgery

Systolic pulmonary pressure result tested by right-sided heart

Change from Baseline pulmonary vascular resistance within 1 monthwithin 1 month before and after pulmonary endarterectomy surgery

Pulmonary vascular resistance result tested by right-sided heart

Change from Baseline cardiac output within 1 monthwithin 1 month before and after pulmonary endarterectomy surgery

Cardiac output result tested by right-sided heart

mortality rate after surgeryimmediately after the surgery to the longest 48 months follow-up period

mortality rate after surgery

Secondary Outcome Measures
NameTimeMethod
Follow-up tricuspid insufficiency level3-24 months after the surgeries

Assessed by UCG

Follow-up right ventricular anterior-posterior diameter3-24 months after the surgeries

Assessed by UCG

Follow-up 6-minutes walking distance6-24 months after the surgeries

Assessed by CPET

Follow-up right ventricular ejection fraction3-24 months after the surgeries

Assessed by UCG

Follow-up tricuspid annular plane systolic excursion3-24 months after the surgeries

Assessed by UCG

Follow-up peak oxygen consumption (Peak O2) result6-24 months after the surgeries

Assessed by cardio-pulmonary exercise test (CPET)

follow-up NYHA classes6-24 months after surgeries

NYHA classes in the follow up period,either with telephone follow-up or out-patient follow up

Follow-up Peak O2%6-24 months after the surgeries

Assessed by CPET

Trial Locations

Locations (1)

Fuwai Hospital,Chinese Academy of Medical Sciences

🇨🇳

Beijing, Beijing, China

© Copyright 2025. All Rights Reserved by MedPath